APA (7th ed.) Citation

Gage, M., Mylander, W., Rosman, M., Fujii, T., Le Du, F., Raghavendra, A., . . . Jackson, R. (2018). Combined pathologic‐genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay. Annals of oncology, 29(5), 1280-1285. https://doi.org/10.1093/annonc/mdy074

Chicago Style (17th ed.) Citation

Gage, M.M, et al. "Combined Pathologic‐genomic Algorithm for Early-stage Breast Cancer Improves Cost-effective Use of the 21-gene Recurrence Score Assay." Annals of Oncology 29, no. 5 (2018): 1280-1285. https://doi.org/10.1093/annonc/mdy074.

MLA (9th ed.) Citation

Gage, M.M, et al. "Combined Pathologic‐genomic Algorithm for Early-stage Breast Cancer Improves Cost-effective Use of the 21-gene Recurrence Score Assay." Annals of Oncology, vol. 29, no. 5, 2018, pp. 1280-1285, https://doi.org/10.1093/annonc/mdy074.